Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Neuroepithelial

Explore clinical trials studying Neoplasms, Neuroepithelial. Study availability and eligibility vary by location and protocol.

2,950 public trials 642 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Neuroepithelial trial results

Recruiting

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

NCT01109394

Conditions
Endocrine Tumors, Eye Diseases, Eye Diseases, Hereditary, +27 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Hospital of Orange County (CHOC Children's) Orange, Florida, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Tisch Cancer Institute, Mount Sinai Medical Center New York, United States
View Trial Details
Recruiting

Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

NCT04040205

Conditions
Chondrosarcoma, Eye Diseases, Eye Diseases, Hereditary, +18 more
Locations
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Washington University in St. Louis St Louis, Missouri, United States
  • Froedtert Hospital & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Recruiting

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

NCT05902169

Conditions
Astrocytoma, GBM, Glioblastoma, +9 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • UCHealth Aurora, Colorado, United States
  • Mayo Clinic of Jacksonville Florida Jacksonville, Florida, United States
View all 51 locations
View Trial Details
Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

NCT05503797

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of California Los Angeles Rheumatology Westwood, Los Angeles, California, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
View all 70 locations
View Trial Details
Recruiting

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

NCT06395103

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +32 more
Locations
  • Children's Hospital Los Angeles ( Site 1006) Los Angeles, California, United States
  • Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016) Aurora, Colorado, United States
  • Yale New Haven Hospital ( Site 1012) New Haven, Connecticut, United States
  • Johns Hopkins All Children's Hospital ( Site 1025) St. Petersburg, Florida, United States
View all 71 locations
View Trial Details
Recruiting

Vorasidenib Maintenance for IDH Mutant Astrocytoma

NCT06809322

Conditions
Astrocytoma, Glioma, IDH-mutant Grade 2 or 3 Astrocytoma, +7 more
Locations
  • Medical University of Innsbruck Innsbruck, Austria
  • Kepler University Hospital - Neuromed campus Linz, Austria
  • Medical University of Vienna Vienna, Austria
  • Universitair Ziekenhuis Brussel Brussels, Belgium
View all 33 locations
View Trial Details

Related conditions